{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:19:33Z","timestamp":1787494773525,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/jcp.0b013e318267b8ca","type":"journal-article","created":{"date-parts":[[2012,8,25]],"date-time":"2012-08-25T02:44:07Z","timestamp":1345862647000},"page":"684-687","source":"Crossref","is-referenced-by-count":31,"title":["Add-on Treatment of Quetiapine for Fibromyalgia"],"prefix":"10.1097","volume":"32","author":[{"given":"St\u00e9phane","family":"Potvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Cloutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Gendron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bissonnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210128","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":". The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee.","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"6","key":"R2-16-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpain.2010.01.002","article-title":"Comparative efficacy and harms of duloxetine, milnacipran and pregabalin in fibromyalgia syndrome.","volume":"11","author":"Hauser","year":"2010","journal-title":"J Pain"},{"key":"R5-16-20210128","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00296-006-0243-z","article-title":"Use of ziprasidone in patients with fibromyalgia: a case series.","volume":"27","author":"Calandre","year":"2007","journal-title":"Rheumatol Int"},{"key":"R6-16-20210128","first-page":"282","article-title":"Beneficial effects of quetiapine treatment in patients with fibromyalgia.","volume":"15","author":"Shemo","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"R7-16-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2006.06.023","article-title":"An open-label study of quetiapine in the treatment of fibromyalgia.","volume":"31","author":"Hidalgo","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R9-16-20210128","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.PSY.0000075977.90337.E7","article-title":"Medically unexplained physical symptoms, anxiety and depression: a meta-analytic review.","volume":"65","author":"Henningsen","year":"2003","journal-title":"Psychosom Med"},{"key":"R10-16-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00023210-200418030-00004","article-title":"Quetiapine: a review of its use in the management of schizophrenia.","volume":"18","author":"Cheer","year":"2004","journal-title":"CNS Drugs"},{"issue":"6","key":"R11-16-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain.","volume":"66","author":"Millan","year":"2002","journal-title":"Prog Neurobiol"},{"key":"R15-16-20210128","first-page":"1054","article-title":". Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the Fibromyalgia Impact Questionnaire.","volume":"30","author":"Perrot","year":"2003","journal-title":"J Rheumatol"},{"key":"R16-16-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"R17-16-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"R19-16-20210128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":". The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"issue":"2","key":"R20-16-20210128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.rdc.2009.05.008","article-title":"The significance of dysfunctions of the sleepingwaking brain to the pathogenesis and treatment of fibromyalgia.","volume":"35","author":"Moldofsky","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"R21-16-20210128","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1345\/aph.1L320","article-title":"Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions.","volume":"43","author":"Wine","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"2","key":"R23-16-20210128","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory.","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"R24-16-20210128","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/art.20485","article-title":". A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.","volume":"50","author":"Arnold","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"11","key":"R25-16-20210128","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1345\/aph.1M193","article-title":"Safety and efficacy of quetiapine in bipolar depression.","volume":"43","author":"Bogart","year":"2009","journal-title":"Ann Pharmacother"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e318267b8ca","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:00:12Z","timestamp":1620943212000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201210000-00016"}},"subtitle":["A Pilot, Randomized, Double-Blind, Placebo-Controlled 12-Week Trial"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318267b8ca","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}